$-1.00 EPS Expected for Eiger BioPharmaceuticals, Inc. (EIGR); Entegris (ENTG) SI Increased By 15.81%

April 17, 2018 - By Clifton Ray

Entegris, Inc. (NASDAQ:ENTG) Logo

Analysts expect Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) to report $-1.00 EPS on May, 11.They anticipate $0.34 EPS change or 25.37% from last quarter’s $-1.34 EPS. After having $-1.11 EPS previously, Eiger BioPharmaceuticals, Inc.’s analysts see -9.91% EPS growth. It closed at $11 lastly. It is down 11.57% since April 17, 2017 and is downtrending. It has underperformed by 23.12% the S&P500.

Entegris Inc (NASDAQ:ENTG) had an increase of 15.81% in short interest. ENTG’s SI was 3.71 million shares in April as released by FINRA. Its up 15.81% from 3.20M shares previously. With 1.50 million avg volume, 3 days are for Entegris Inc (NASDAQ:ENTG)’s short sellers to cover ENTG’s short positions. The SI to Entegris Inc’s float is 2.84%. The stock increased 2.21% or $0.8146 during the last trading session, reaching $37.7146. About 493,516 shares traded. Entegris, Inc. (NASDAQ:ENTG) has risen 54.03% since April 17, 2017 and is uptrending. It has outperformed by 42.48% the S&P500.

Among 13 analysts covering Entegris (NASDAQ:ENTG), 12 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Entegris had 30 analyst reports since August 3, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Entegris, Inc. (NASDAQ:ENTG) on Thursday, January 26 with “Buy” rating. KeyBanc Capital Markets maintained Entegris, Inc. (NASDAQ:ENTG) rating on Tuesday, February 6. KeyBanc Capital Markets has “Buy” rating and $37.0 target. The stock of Entegris, Inc. (NASDAQ:ENTG) has “Buy” rating given on Monday, September 18 by Needham. The rating was maintained by KeyBanc Capital Markets on Wednesday, March 21 with “Overweight”. Needham initiated the stock with “Hold” rating in Monday, November 21 report. Dougherty & Company maintained Entegris, Inc. (NASDAQ:ENTG) on Friday, February 3 with “Buy” rating. The company was maintained on Wednesday, March 21 by Craig Hallum. The firm has “Buy” rating by Goldman Sachs given on Friday, February 10. The firm has “Buy” rating by Needham given on Thursday, October 26. The stock of Entegris, Inc. (NASDAQ:ENTG) earned “Buy” rating by Citigroup on Thursday, February 15.

Entegris, Inc. develops, manufactures, and supplies micro contamination control products, specialty chemicals, and advanced materials handling solutions for manufacturing processes in the semiconductor and other high-technology industries worldwide. The company has market cap of $5.35 billion. The firm operates in three divisions: Specialty Chemicals and Engineered Materials, Advanced Materials Handling, and Microcontamination Control. It has a 63.92 P/E ratio. The Specialty Chemicals and Engineered Materials segment provides high-performance and high-purity process chemistries, gases, and materials, as well as safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.

Since December 14, 2017, it had 0 insider buys, and 8 selling transactions for $9.53 million activity. On Tuesday, March 6 the insider BRADLEY MICHAEL A sold $548,307. Rucci Corey sold $338,485 worth of stock or 9,986 shares. GRAVES GREGORY B sold 56,478 shares worth $1.90 million. Shares for $5.86M were sold by LOY BERTRAND. OLSON PAUL L H had sold 3,000 shares worth $90,628 on Thursday, December 14. $252,236 worth of stock was sold by Edlund Todd James on Thursday, March 8. 9,889 shares were sold by Shaner William James, worth $333,312 on Tuesday, February 27.

Entegris, Inc. (NASDAQ:ENTG) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: